Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
出版年份 2018 全文链接
标题
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-07-30
DOI
10.1038/s41598-018-29639-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liver disease alters high-density lipoprotein composition, metabolism and function
- (2016) Markus Trieb et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis
- (2016) Julie Gall et al. Journal of the American Heart Association
- Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
- (2016) Wijtske Annema et al. Scientific Reports
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT
- (2015) Diego Lucero et al. ATHEROSCLEROSIS
- Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL
- (2015) Patrick M. Hutchins et al. CURRENT OPINION IN LIPIDOLOGY
- Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease
- (2015) Alper Sonmez et al. Journal of Clinical Lipidology
- High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity
- (2015) Anand Rohatgi PROGRESS IN CARDIOVASCULAR DISEASES
- Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
- (2015) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- 2. Classification and Diagnosis of Diabetes
- (2014) DIABETES CARE
- Lipoprotein subclass metabolism in nonalcoholic steatohepatitis
- (2014) Ville T. Männistö et al. JOURNAL OF LIPID RESEARCH
- HDL and cardiovascular disease
- (2014) Daniel J Rader et al. LANCET
- Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes
- (2014) Hussein N. Yassine et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
- (2013) Andrew Paul DeFilippis et al. ATHEROSCLEROSIS
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models
- (2012) H. Low et al. DIABETOLOGIA
- Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
- (2012) Enzo Bonora et al. Nature Reviews Gastroenterology & Hepatology
- Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?
- (2011) Xavier Rousset et al. Current Atherosclerosis Reports
- Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects
- (2011) P Nestel et al. INTERNATIONAL JOURNAL OF OBESITY
- HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
- (2011) Mohamad Navab et al. Nature Reviews Cardiology
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease
- (2011) Xavier Rousset et al. Current Opinion in Endocrinology Diabetes and Obesity
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages
- (2010) Margarita de la Llera-Moya et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus
- (2009) Huali Zhou et al. Diabetes & Vascular Disease Research
- Cellular cholesterol efflux to serum is impaired in diabetic nephropathy
- (2008) Huali Zhou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
- (2008) Robin P F Dullaart et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now